About TearLab
TearLab is a company based in San Diego (United States) founded in 2003 was acquired by Accelmed in May 2020. TearLab has completed 1 acquisition, including OcuHub. TearLab operates in a competitive market with competitors including Toku Eyes, Quantel Medical, Cassini, BioLight and Pr3vent, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tearlab Corp
-
Annual Revenue
$22.66 M (USD)-9as on Dec 31, 2019
-
Net Profit
-$5.42 M (USD)-141as on Dec 31, 2019
-
EBITDA
$722 K (USD)-79as on Dec 31, 2019
-
Latest Funding Round
$1.75 M (USD), Post-IPO
Oct 08, 2015
-
Investors
CRG
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Accelmed
(May 11, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of TearLab
Unlock access to complete
Unlock access to complete
Funding Insights of TearLab
Investors in TearLab
TearLab has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CRG and Accelmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for TearLab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TearLab
TearLab has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OcuHub.
Investment portfolio details for TearLab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloud-based health information platform for payers and doctors
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for TearLab
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TearLab
Detailed financials for TearLab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tearlab Comparisons
Peer comparison for TearLab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TearLab
TearLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Toku Eyes, Quantel Medical, Cassini, BioLight and Pr3vent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered retinal images are analyzed for early disease detection.
|
|
| Locked | Locked | Locked |
Ultrasound and laser devices for ophthalmology are manufactured and marketed.
|
|
| Locked | Locked | Locked |
Corneal diagnostic solutions for astigmatism and topography are offered.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for ophthalmology
|
|
| Locked | Locked | Locked |
AI-based platform for newborn ophthalmic condition screening is offered.
|
Detailed competitors of TearLab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tearlab
Complete news archive for TearLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TearLab
TearLab was founded in 2003 and raised its 1st funding round 6 years after it was founded.
TearLab is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Seph Jensen is the current CEO of TearLab.
Annual revenue of TearLab is $22.66M as on Dec 31, 2019.
TearLab develops diagnostics for hyperosmolarty. The company offers the TearLab Osmolarity Test for revealing tear film osmolarity (a sign of dry eye disease) by testing for disease markers in tears. The test is done using its proprietary TearLab point-of-care instrument.
TearLab has made 1 acquisition, including OcuHub.
TearLab has 2 investors. Key investors include CRG, and Accelmed.